Kumari P, Sullivan L, Li Z, Parker Conquest E, Cornforth E, Jayakumar R
Nat Commun. 2025; 16(1):2158.
PMID: 40044661
PMC: 11882899.
DOI: 10.1038/s41467-025-56479-5.
Zhu G, Siegel C, Rogers D, Sagel J, Morrell G, Olpin J
Abdom Radiol (NY). 2025; .
PMID: 39890634
DOI: 10.1007/s00261-024-04714-w.
Heidebrecht Jr R, Jozefiak T, Shain H, Skrabut E, Saunders D, Smith N
PLoS One. 2025; 20(1):e0317790.
PMID: 39854411
PMC: 11760559.
DOI: 10.1371/journal.pone.0317790.
Su D, Krongbaramee T, Swearson S, Sweat Y, Sweat M, Shao F
JCI Insight. 2025; 10(1.
PMID: 39782692
PMC: 11721312.
DOI: 10.1172/jci.insight.179815.
Elmasri M, Clark A, Grundy L
Brain Sci. 2025; 14(12.
PMID: 39766402
PMC: 11675006.
DOI: 10.3390/brainsci14121203.
Distinctive roles of aquaporins and novel therapeutic opportunities against cancer.
Yadav D, Singh D, Shin D
RSC Med Chem. 2024; .
PMID: 39697243
PMC: 11650210.
DOI: 10.1039/d4md00786g.
IFRD1 is required for maintenance of bladder epithelial homeostasis.
Fashemi B, Rougeau A, Salazar A, Bark S, Chappidi R, Brown J
iScience. 2024; 27(12):111282.
PMID: 39628564
PMC: 11613175.
DOI: 10.1016/j.isci.2024.111282.
Bacterial-host adhesion dominated by collagen subtypes remodelled by osmotic pressure.
Xu H, Feng Y, Du Y, Han Y, Duan X, Jiang Y
NPJ Biofilms Microbiomes. 2024; 10(1):124.
PMID: 39532878
PMC: 11557999.
DOI: 10.1038/s41522-024-00600-x.
Device-Assisted Therapy in Non-Muscle-Invasive Bladder Cancer.
Gurram S, Rathi N
Bladder Cancer. 2024; 10(3):167-182.
PMID: 39493816
PMC: 11530031.
DOI: 10.3233/BLC-240032.
Periderm fate and independence of tooth formation are conserved across osteichthyans.
Huysseune A, Horackova A, Suchanek T, Larionova D, Cerny R
Evodevo. 2024; 15(1):13.
PMID: 39363199
PMC: 11451126.
DOI: 10.1186/s13227-024-00232-4.
Emerging molecular therapies in the treatment of bladder cancer.
Bell S, Quinn A, Spitzer T, Voss B, Wakefield M, Fang Y
Explor Target Antitumor Ther. 2024; 5(5):1135-1154.
PMID: 39351439
PMC: 11438598.
DOI: 10.37349/etat.2024.00267.
Recent Advances in Drug Delivery Strategies for High-Risk BCG-Unresponsive Non-Muscle Invasive Bladder Cancer: A Brief Review from 2018 to 2024.
Qu F, Darji S, Thompson D
Pharmaceutics. 2024; 16(9).
PMID: 39339191
PMC: 11434993.
DOI: 10.3390/pharmaceutics16091154.
Case reports of immune-related cystitis and the antibody combination hypothesis.
Zhang P, Yin C, Yang M
Immunotherapy. 2024; 16(16-17):1039-1047.
PMID: 39263930
PMC: 11492643.
DOI: 10.1080/1750743X.2024.2389761.
A biodegradable microgrooved and tissue mechanocompatible citrate-based scaffold improves bladder tissue regeneration.
Goedegebuure M, Bury M, Wang X, Sanfelice P, Cammarata F, Wang L
Bioact Mater. 2024; 41:553-563.
PMID: 39246838
PMC: 11380464.
DOI: 10.1016/j.bioactmat.2024.07.030.
A Dynamic Interplay of Innate Immune Responses During Urinary Tract Infection.
Naskar M, Choi H
Immune Netw. 2024; 24(4):e31.
PMID: 39246616
PMC: 11377947.
DOI: 10.4110/in.2024.24.e31.
Untethered Microgrippers for Biopsy in the Upper Urinary Tract.
Liu W, Alam R, Choi S, Wan Y, Zhang R, Baraban E
Adv Healthc Mater. 2024; 13(29):e2401407.
PMID: 39101622
PMC: 11584312.
DOI: 10.1002/adhm.202401407.
RNA-seq gene expression profiling of the bladder in a mouse model of urogenital schistosomiasis.
Ishida K, Osakunor D, Rossi M, Lamanna O, Mbanefo E, Cody J
bioRxiv. 2024; .
PMID: 38979184
PMC: 11230422.
DOI: 10.1101/2024.06.29.601185.
Pictorial review of multiparametric MRI in bladder urothelial carcinoma with variant histology: pearls and pitfalls.
Arita Y, Woo S, Kwee T, Shigeta K, Ueda R, Nalavenkata S
Abdom Radiol (NY). 2024; 49(8):2797-2811.
PMID: 38847848
DOI: 10.1007/s00261-024-04397-3.
Mitigating candidiasis with acarbose by targeting Candida albicans α-glucosidase: in-silico, in-vitro and transcriptomic approaches.
David H, Vasudevan S, Solomon A
Sci Rep. 2024; 14(1):11890.
PMID: 38789465
PMC: 11126738.
DOI: 10.1038/s41598-024-62684-x.
Strategies of Bladder Reconstruction after Partial or Radical Cystectomy for Bladder Cancer.
Zeng X, Wu Y
Mol Biotechnol. 2024; .
PMID: 38761327
DOI: 10.1007/s12033-024-01163-0.